Literature DB >> 19177359

High tolerance to simultaneous active-site mutations in TEM-1 beta-lactamase: Distinct mutational paths provide more generalized beta-lactam recognition.

Pierre-Yves De Wals1, Nicolas Doucet, Joelle N Pelletier.   

Abstract

The diversity in substrate recognition spectra exhibited by various beta-lactamases can result from one or a few mutations in the active-site area. Using Escherichia coli TEM-1 beta-lactamase as a template that efficiently hydrolyses penicillins, we performed site-saturation mutagenesis simultaneously on two opposite faces of the active-site cavity. Residues 104 and 105 as well as 238, 240, and 244 were targeted to verify their combinatorial effects on substrate specificity and enzyme activity and to probe for cooperativity between these residues. Selection for hydrolysis of an extended-spectrum cephalosporin, cefotaxime (CTX), led to the identification of a variety of novel mutational combinations. In vivo survival assays and in vitro characterization demonstrated a general tendency toward increased CTX and decreased penicillin resistance. Although selection was undertaken with CTX, productive binding (K(M)) was improved for all substrates tested, including benzylpenicillin for which catalytic turnover (k(cat)) was reduced. This indicates broadened substrate specificity, resulting in more generalized (or less specialized) variants. In most variants, the G238S mutation largely accounted for the observed properties, with additional mutations acting in an additive fashion to enhance these properties. However, the most efficient variant did not harbor the mutation G238S but combined two neighboring mutations that acted synergistically, also providing a catalytic generalization. Our exploration of concurrent mutations illustrates the high tolerance of the TEM-1 active site to multiple simultaneous mutations and reveals two distinct mutational paths to substrate spectrum diversification.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19177359      PMCID: PMC2708040          DOI: 10.1002/pro.25

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  50 in total

Review 1.  How beta-lactamases have driven pharmaceutical drug discovery. From mechanistic knowledge to clinical circumvention.

Authors:  K Bush; S Mobashery
Journal:  Adv Exp Med Biol       Date:  1998       Impact factor: 2.622

2.  Predicting the emergence of antibiotic resistance by directed evolution and structural analysis.

Authors:  M C Orencia; J S Yoon; J E Ness; W P Stemmer; R C Stevens
Journal:  Nat Struct Biol       Date:  2001-03

Review 3.  Enzyme catalysis: removing chemically 'essential' residues by site-directed mutagenesis.

Authors:  A Peracchi
Journal:  Trends Biochem Sci       Date:  2001-08       Impact factor: 13.807

4.  Robustness, evolvability, and neutrality.

Authors:  Andreas Wagner
Journal:  FEBS Lett       Date:  2005-03-21       Impact factor: 4.124

Review 5.  Semi-rational approaches to engineering enzyme activity: combining the benefits of directed evolution and rational design.

Authors:  Roberto A Chica; Nicolas Doucet; Joelle N Pelletier
Journal:  Curr Opin Biotechnol       Date:  2005-08       Impact factor: 9.740

Review 6.  Enzyme promiscuity: evolutionary and mechanistic aspects.

Authors:  Olga Khersonsky; Cintia Roodveldt; Dan S Tawfik
Journal:  Curr Opin Chem Biol       Date:  2006-08-30       Impact factor: 8.822

7.  Evolution toward small molecule inhibitor resistance affects native enzyme function and stability, generating acarbose-insensitive cyclodextrin glucanotransferase variants.

Authors:  Ronan M Kelly; Hans Leemhuis; Linda Gätjen; Lubbert Dijkhuizen
Journal:  J Biol Chem       Date:  2008-02-18       Impact factor: 5.157

8.  Crystal structure and activity studies of the Mycobacterium tuberculosis beta-lactamase reveal its critical role in resistance to beta-lactam antibiotics.

Authors:  Feng Wang; Craig Cassidy; James C Sacchettini
Journal:  Antimicrob Agents Chemother       Date:  2006-08       Impact factor: 5.191

9.  The high resolution crystal structure for class A beta-lactamase PER-1 reveals the bases for its increase in breadth of activity.

Authors:  S Tranier; A T Bouthors; L Maveyraud; V Guillet; W Sougakoff; J P Samama
Journal:  J Biol Chem       Date:  2000-09-08       Impact factor: 5.157

10.  Role of Asp104 in the SHV beta-lactamase.

Authors:  Christopher R Bethel; Andrea M Hujer; Kristine M Hujer; Jodi M Thomson; Mark W Ruszczycky; Vernon E Anderson; Marianne Pusztai-Carey; Magdalena Taracila; Marion S Helfand; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2006-09-18       Impact factor: 5.191

View more
  6 in total

1.  Structure-based design of combinatorial mutagenesis libraries.

Authors:  Deeptak Verma; Gevorg Grigoryan; Chris Bailey-Kellogg
Journal:  Protein Sci       Date:  2015-03-02       Impact factor: 6.725

2.  Pareto Optimization of Combinatorial Mutagenesis Libraries.

Authors:  Deeptak Verma; Gevorg Grigoryan; Chris Bailey-Kellogg
Journal:  IEEE/ACM Trans Comput Biol Bioinform       Date:  2018-07-23       Impact factor: 3.710

3.  Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.

Authors:  Philippe Egesborg; Hélène Carlettini; Jordan P Volpato; Nicolas Doucet
Journal:  Protein Sci       Date:  2014-12-30       Impact factor: 6.725

4.  Screening of inhibitors for S130G inhibitor resistant mutants of TEM type beta-lactamase.

Authors:  Mohd Hassan Baig; Mohd Danishuddin; Saif Khan; Asad U Khan
Journal:  Bioinformation       Date:  2012-12-08

5.  Natural variants modify Klebsiella pneumoniae carbapenemase (KPC) acyl-enzyme conformational dynamics to extend antibiotic resistance.

Authors:  Catherine L Tooke; Philip Hinchliffe; Robert A Bonomo; Christopher J Schofield; Adrian J Mulholland; James Spencer
Journal:  J Biol Chem       Date:  2020-12-03       Impact factor: 5.157

6.  Chimeric β-lactamases: global conservation of parental function and fast time-scale dynamics with increased slow motions.

Authors:  Christopher M Clouthier; Sébastien Morin; Sophie M C Gobeil; Nicolas Doucet; Jonathan Blanchet; Elisabeth Nguyen; Stéphane M Gagné; Joelle N Pelletier
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.